Sera Prognostics, Inc. Profile Avatar - Palmy Investing

Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous prete…

Medical - Diagnostics & Research
US, Salt Lake City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Sera Prognostics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SERA's Analysis
CIK: 1534969 CUSIP: 81749D107 ISIN: US81749D1072 LEI: - UEI: -
Secondary Listings
SERA has no secondary listings inside our databases.